Your browser doesn't support javascript.
loading
Development of forced normalisation psychosis with ethosuximide.
Apap Mangion, Sean; Rugg-Gunn, Fergus.
Afiliación
  • Apap Mangion S; Department of Telemetry, University College London, Institute of Neurology, London, UK.
  • Rugg-Gunn F; Deparment of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
BMJ Case Rep ; 20172017 Dec 07.
Article en En | MEDLINE | ID: mdl-29222216
A 50-year-old man with known multidrug resistant coexistent focal and generalised epilepsy was commenced on ethosuximide, with normalisation of his electroencephalogram and cessation of absence seizures. Within 3 weeks, he developed a rapidly worsening paranoid psychosis with visual and olfactory hallucinations. A month after the cessation of ethosuximide and concurrent treatment with olanzapine, his psychosis resolved and permitted reinitiation of ethosuximide at a lower dose without recurrence of psychotic symptoms.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Epilepsia / Etosuximida / Alucinaciones / Anticonvulsivantes Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans / Male / Middle aged Idioma: En Revista: BMJ Case Rep Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Epilepsia / Etosuximida / Alucinaciones / Anticonvulsivantes Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Humans / Male / Middle aged Idioma: En Revista: BMJ Case Rep Año: 2017 Tipo del documento: Article